The FDA approved the Tecnis PureSee IOL, an extended depth of focus IOL for cataract surgery, according to a press release ...
Johnson & Johnson (NYSE: JNJ) announced that it received FDA approval for its Tecnis PureSee intraocular lens (IOL) for cataract surgery.
GlobalData on MSN
FDA approves J&J’s TECNIS PureSee intraocular lens
The TECNIS PureSee IOL addresses both cataract-related vision loss and presbyopia, which affects near vision as eyes age.
This outpatient procedure is a safe and effective way to improve your vision—and many patients say it’s life-changing.
With millions of Americans having undergone LASIK vision correction in the past three decades, a growing number are now approaching the age where cataract surgery becomes a consideration. Porter ...
FDA approval supports US commercialization of TECNIS PureSee, an EDOF IOL for implantation during cataract surgery, with availability anticipated later in 2026. PureSee is positioned to preserve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results